Miltown-600 en es it fr

Miltown-600 Brand names, Miltown-600 Analogs

Miltown-600 Brand Names Mixture

  • No information avaliable

Miltown-600 Chemical_Formula

C20H23NS

Miltown-600 RX_link

No information avaliable

Miltown-600 fda sheet

Miltown-600 msds (material safety sheet)

Miltown-600 Synthesis Reference

No information avaliable

Miltown-600 Molecular Weight

309.469 g/mol

Miltown-600 Melting Point

< 25 oC

Miltown-600 H2O Solubility

Soluble as HCl salt

Miltown-600 State

Liquid

Miltown-600 LogP

5.7

Miltown-600 Dosage Forms

Tablets (oral, 1 mg)

Miltown-600 Indication

Used for the symptomatic treatment of parkinsonism.

Miltown-600 Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Miltown-600 Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Miltown-600 side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Miltown-600 Patient Information

Miltown-600 Organisms Affected

Humans and other mammals